Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Lumify™ (Brimonidine Tartrate Ophthalmic Solution 0.025%) on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Using Brimonidine 0.2%, 0.15%, or 0.1%

NCT04007276 is registered in ClinicalTrials.gov with Tulane University as lead sponsor.

NCT NCT04007276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04007276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Lumify™ (Brimonidine Tartrate Ophthalmic Solution 0.025%) on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Using Brimonidine 0.2%, 0.15%, or 0.1%
Lead sponsor
Tulane University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 30, 2027
Completion date
November 30, 2036
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

droopy eyelid, glaucoma, glaucoma, open-angle, glaucoma, primary open angle, glaucoma; drugs, ptosis